News
Griffith University researchers have found weaker neck strength is a risk factor for concussion and higher head impacts in ...
Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in metastatic NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback